Formoterol in Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT07022418
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Registry
-
NCT07022418
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07022418. Randomized; no masking; primary purpose treatment. Start 2025-12-01 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Formoterol in Diabetes
- Condition
- Diabetic Nephropathies
- Condition
- Diabetic Kidney Disease
- Intervention (Drug)
- Formoterol furmarate (20 μg)
- Lead sponsor
- Medical University of South Carolina
- Collaborator
- Dialysis Clinic, Inc.
Record details
- Record id
cardio:ct-nct07022418- Content hash
d1adcab8b19b1563809f84167e392a3bd39cefbc5aea8957df9d7de43f6e5140